Business Context and Reporting Period
Company: Organigram Global Inc.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Three months ended December 31, 2025
Filing Date: February 10, 2026
Principal Executive Offices: Toronto, Ontario, Canada
Key Financial Metrics
The provided filing text contains only the cover page and exhibit list for Form 6-K. It references the submission of financial statements and management discussion but does not include the actual numerical data. Consequently, the following metrics are not available in the source text:
- Revenue
- Profit (Net Income/Loss)
- Cash Flow
- Margins
- Debt and Liquidity
Note: The filing text does not provide a clear value for any financial metric.
Material Changes
The source text does not contain comparative data or narrative descriptions of material changes versus the prior comparable period. This information is expected to be contained within the referenced exhibits (99.1 and 99.2) which are not included in the input.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, forward-looking guidance, risk factors, contingencies, or details on unusual items. These disclosures are typically found in the Management's Discussion and Analysis (Exhibit 99.1) and the News Release (Exhibit 99.5), the content of which is not present in the provided text.
Investor Verification Checklist
- Verify the actual revenue and net income figures in the Condensed Consolidated Interim Unaudited Financial Statements (Exhibit 99.2).
- Review the Management's Discussion and Analysis (Exhibit 99.1) for explanations of performance trends and liquidity status.
- Check the News Release (Exhibit 99.5) for specific guidance updates and material risk disclosures.
- Confirm the status of the company's Form 40-F filing requirement as indicated by the checkmark on the cover page.